PGx test for statin-induced myopathy cost effective

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-018-45277-3
中图分类号
学科分类号
摘要
引用
收藏
页码:8 / 8
相关论文
共 50 条
  • [41] Effects of insulin on statin-induced myopathy and insulin resistance
    Sanvee, M.
    Bouitbir, J.
    Krahenbuhl, S.
    TOXICOLOGY LETTERS, 2016, 258 : S236 - S236
  • [43] A Case Series of Statin-Induced Necrotizing Autoimmune Myopathy
    Sharma, Alisha
    Musurakis, Clio
    Nabil, Nur Un Nisa
    Poudel, Bidhya
    Trongtorsak, Angkawipa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [44] Impact of vitamin D status on statin-induced myopathy
    Riche, Krista D.
    Arnall, Justin
    Rieser, Kristin
    East, Honey E.
    Riche, Daniel M.
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2016, 6 : 56 - 59
  • [45] Oxidative stress as a possible mechanism of statin-induced myopathy
    Ahmadi, Yasin
    Ghorbanihaghjo, Amir
    Naghi-Zadeh, Mohsen
    Yagin, Neda Lotfi
    INFLAMMOPHARMACOLOGY, 2018, 26 (03) : 667 - 674
  • [46] Pharmacogenomic insights into treatment and management of statin-induced myopathy
    Bas JM Peters
    Olaf H Klungel
    Frank L Visseren
    Anthonius de Boer
    Anke-Hilse Maitland-van der Zee
    Genome Medicine, 1
  • [47] Current views on lipid metabolism: statin-induced myopathy
    Teichmann, L. L.
    Fleck, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (08): : 696 - +
  • [48] Whole exome sequencing in individuals with statin-induced myopathy
    Bloch, K. M.
    Carr, D.
    Pirmohamed, M.
    Morris, A.
    Maroteau, C.
    Eriksson, N.
    Wadelius, M.
    Palmer, C.
    Alfirevic, A.
    DRUG SAFETY, 2017, 40 (10) : 1026 - 1026
  • [49] Role of thyroid disease in the development of statin-induced myopathy
    Rush, Jordan
    Danzi, Sara
    Klein, Irwin
    ENDOCRINOLOGIST, 2006, 16 (05): : 279 - 285
  • [50] Effects of insulin on statin-induced myopathy and insulin resistance
    Hanak, Anne-Sophie
    Malissin, Isabelle
    Poupon, Joel
    Risede, Patricia
    Chevillard, Lucie
    Megarbane, Bruno
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 498 - 498